CompletedNot Applicable

Pharmacist Provision of Medication Abortion

United States10 participantsStarted 2022-01-12

Plain-language summary

This will be a pilot study among two pharmacists providing start to finish medication abortions to 10 patients utilizing a previously created toolkit. Following completion of the pilot, we will perform in-depth semi-structured interviews with the participating patients and pharmacists to understand their experiences with pharmacist provision of medication abortion. In addition, we will elicit feedback about ways to refine the toolkit to support the scale-up of pharmacist provision of medication abortion in the future.

Who can participate

Age range18 Years – 50 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Hemorrhagic bleeding disorder
✕. Current anticoagulation therapy
✕. Chronic adrenal failure
✕. Long-term systemic corticosteroid therapy
✕. Inherited porphyria
✕. Poorly controlled hypertension as defined a history of systolic blood pressure \>160 or diastolic blood pressure \>110 or patients requiring two or more antihypertensive medication to control their blood pressure. This will be exclusion criteria for the study but it not a standard exclusion criteria for medication abortion
✕. Poorly controlled diabetes as defined by a known history of Type 1 or Type 2 diabetes with history of finger stick blood sugar \>200 or HbA1c\>10 in the last 6 months. This will be exclusion criteria for the study but it not a standard exclusion criteria for medication abortion
✕. Hepatic or renal failure

What they're measuring

Completion of Medication Abortion

Timeframe: 6 weeks

Trial details

NCT IDNCT04956731

SponsorUniversity of California, San Diego

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-08-05

Results submitted2024-05-21

View on ClinicalTrials.gov More Abortion in First Trimester trials